776
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Nomogram establishment for short-term survival prediction in ICU patients with aplastic anemia based on the MIMIC-IV database

, , &
Article: 2339778 | Received 24 Jan 2024, Accepted 27 Mar 2024, Published online: 16 Apr 2024

Reference

  • Drexler B, Zurbriggen F, Diesch T, et al. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation. Ann Hematol. 2020;99(11):2529–2538. doi:10.1007/s00277-020-04271-4
  • Vaht K, Goransson M, Carlson K, et al. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011. Haematologica. 2017;102(10):1683–1690. doi:10.3324/haematol.2017.169862
  • Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129(11):1428–1436. doi:10.1182/blood-2016-08-693481
  • Geng C, Liu X, Chen M, et al. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - a meta analysis. Leuk Res. 2020;88:106266. doi:10.1016/j.leukres.2019.106266
  • Luzzatto L, Risitano AM. Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol. 2018;182(6):758–776. doi:10.1111/bjh.15443
  • Boddu PC, Kadia TM. Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review. Expert Rev Hematol. 2017;10(5):433–448. doi:10.1080/17474086.2017.1313700
  • Yamazaki H, Ohta K, Iida H, et al. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy. Int J Hematol. 2019;110(2):187–196. doi:10.1007/s12185-019-02683-1
  • Scheinberg P. Recent advances and long-term results of medical treatment of acquired aplastic anemia: are patients cured? Hematol Oncol Clin North Am. 2018;32(4):609–618. doi:10.1016/j.hoc.2018.03.003
  • Patel BA, Groarke EM, Lotter J, et al. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study. Blood. 2022;139(1):34–43. doi:10.1182/blood.2021012130
  • Tichelli A, de Latour RP, Passweg J, et al. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a severe aplastic anemia working party trial from the European group of blood and marrow transplantation. Haematologica. 2020;105(5):1223–1231. doi:10.3324/haematol.2019.222562
  • Xu LP, Yu Y, Cheng YF, et al. Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation. Br J Haematol. 2022;196(3):735–742. doi:10.1111/bjh.17916
  • Barade A, Aboobacker F, Korula A, et al. Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia. Br J Haematol. 2022;196(3):724–734. doi:10.1111/bjh.17880
  • Dorken Gallastegi A, Gebran A, Gaitanidis A, et al. Early versus late enteral nutrition in critically ill patients receiving vasopressor support. JPEN J Parenter Enteral Nutr. 2022;46(1):130–140. doi:10.1002/jpen.2266
  • Zhou W, Fan C, He S, et al. Impact of platelet transfusion thresholds on outcomes of patients With sepsis: analysis of the MIMIC-IV database. Shock. 2022;57(4):486–493. doi:10.1097/SHK.0000000000001898
  • Zhang XT, Wang X, Cao J, et al. Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience. Hematology. 2021;26(1):1025–1030. doi:10.1080/16078454.2021.2009646
  • Camitta BM, Storb R, Thomas ED. Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med. 1982;306(11):645–652. doi:10.1056/NEJM198203183061105
  • Camitta BM, Storb R, Thomas ED. Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med. 1982;306(12):712–718. doi:10.1056/NEJM198203253061204
  • Yoon HH, Huh SJ, Lee JH, et al. Should we still use Camitta's criteria for severe aplastic anemia? Korean J Hematol. 2012;47(2):126–130. doi:10.5045/kjh.2012.47.2.126
  • Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187–207. doi:10.1111/bjh.13853
  • Dorofeeva AI, Shipunova IN, Luchkin AV, et al. Differences in the differentiation potential and relative levels of gene expression in the bone marrow-derived fibroblast colony-forming units in patients during the onset of aplastic anemia depending on the disease severity. Bull Exp Biol Med. 2023;174(4):538–543. doi:10.1007/s10517-023-05744-y
  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
  • Haddad IY. Stem cell transplantation and lung dysfunction. Curr Opin Pediatr. 2013;25(3):350–356. doi:10.1097/MOP.0b013e328360c317
  • John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest. 2005;127(3):825–829. doi:10.1378/chest.127.3.825
  • Kacmarek RM, Villar J, Parrilla D, et al. Neurally adjusted ventilatory assist in acute respiratory failure: a randomized controlled trial. Intensive Care Med. 2020;46(12):2327–2337. doi:10.1007/s00134-020-06181-5.
  • Rackley CR. Monitoring during mechanical ventilation. Respir Care. 2020;65(6):832–846. doi:10.4187/respcare.07812
  • Rialp G. Mechanical ventilation: past and present. Med Intensiva (Engl Ed). 2021;45(1):1–2. doi:10.1016/j.medin.2020.08.012
  • Yang J, Zhang L, Wang H, et al. Protective effects of chronic intermittent hypobaric hypoxia pretreatment against aplastic anemia through improving the adhesiveness and stress of mesenchymal stem cells in rats. Stem Cells Int. 2017;2017:5706193.
  • Makeshova AB, Eralieva MO, Levina AA, et al. Particular features of erythropoiesis in high altitude and possibilities of applying of hypoxic hypoxia methodology for the patients with hemopoietic suppression. Voen Med Zh. 2013;334(7):38–45.
  • Huang J, Pu Y, Xu K, et al. High expression of HIF-1alpha alleviates benzene-induced hematopoietic toxicity and immunosuppression in mice. Environ Pollut. 2022;311:119928. doi:10.1016/j.envpol.2022.119928
  • Liu Z, Chen L, Xiong D, et al. Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1alpha/RORgammat pathway. Redox Rep. 2023;28(1):2225868. doi:10.1080/13510002.2023.2225868
  • Wallner B, Schenk B, Hermann M, et al. Hypothermia-associated coagulopathy: a comparison of viscoelastic monitoring, platelet function, and real time live confocal microscopy at low blood temperatures, an in vitro experimental study. Front Physiol. 2020;11:843. doi:10.3389/fphys.2020.00843
  • Lee H, Kong SY, Sohn JY, et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Biomed Res Int. 2014;2014:145619.
  • Perisa V, Zibar L, Sincic-Petricevic J, et al. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study. Croat Med J. 2015;56(4):334–343. doi:10.3325/cmj.2015.56.334
  • Podhorecka M, Halicka D, Szymczyk A, et al. Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia. Oncotarget. 2016;7(22):32846–32853. doi:10.18632/oncotarget.9055
  • Mao XL, Xi YM, Li ZJ, et al. Higher red blood cell distribution width at diagnose is a simple negative prognostic factor in chronic phase-chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: A retrospective study. Medicine (Baltimore). 2021;100(10):e24003. doi:10.1097/MD.0000000000024003
  • Bai Z, Hu S, Wang Y, et al. Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction. Ann Transl Med. 2021;9(14):1162. doi:10.21037/atm-21-2905
  • Bacigalupo A. Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation? Hematology Am Soc Hematol Educ Program. 2012;2012:223–229. doi:10.1182/asheducation.V2012.1.223.3798305
  • Giammarco S, Peffault de Latour R, Sica S, et al. Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved? Blood. 2018;131(17):1989–1992. doi:10.1182/blood-2017-09-807859
  • Meyers G, Maziarz RT. Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia. Bone Marrow Transplant. 2010;45(10):1479–1488. doi:10.1038/bmt.2010.134